ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 93 filers reported holding ORIC PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 0.86 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $137 | -89.6% | 22,691 | -86.7% | 0.00% | -80.0% |
| Q2 2023 | $1,322 | +77.7% | 170,488 | +30.5% | 0.01% | +66.7% |
| Q1 2023 | $744 | -1.1% | 130,655 | +2.2% | 0.00% | -25.0% |
| Q4 2022 | $752 | -99.8% | 127,851 | 0.0% | 0.00% | +100.0% |
| Q3 2022 | $408,000 | -20.2% | 127,851 | +11.9% | 0.00% | -33.3% |
| Q2 2022 | $511,000 | +1662.1% | 114,216 | +1974.0% | 0.00% | – |
| Q1 2022 | $29,000 | – | 5,507 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 496,893 | $16,760,000 | 14.90% |
| Svennilson Peter | 4,768,181 | $160,831,000 | 13.45% |
| Invus Financial Advisors, LLC | 1,007,576 | $33,986,000 | 12.28% |
| EcoR1 Capital, LLC | 2,642,218 | $89,122,000 | 6.58% |
| Foresite Capital Management IV, LLC | 125,000 | $4,216,000 | 2.05% |
| Orbimed Advisors | 2,921,967 | $98,558,000 | 1.39% |
| Casdin Capital, LLC | 251,515 | $8,484,000 | 0.50% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 191,568 | $6,462,000 | 0.50% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 300,000 | $10,119,000 | 0.30% |
| EMERALD ADVISERS, LLC | 186,140 | $6,279,000 | 0.27% |